These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7973211)

  • 21. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review.
    Rowell NP; Williams CJ
    Thorax; 2001 Aug; 56(8):628-38. PubMed ID: 11462066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.
    Stuschke M; Thames HD
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):259-67. PubMed ID: 9069295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer versus conventionally fractionated 60 Gy: results of a randomized equivalence study].
    Zagamé L; Noël G; Mazeron JJ
    Cancer Radiother; 2001 Apr; 5(2):199. PubMed ID: 11355587
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chemoradiotherapy. Therapeutic indications: the doctor's point of view].
    Natale D; Orlando D
    Suppl Tumori; 2004; 3(4):S123-4. PubMed ID: 15206236
    [No Abstract]   [Full Text] [Related]  

  • 25. Lung cancer.
    Neville A
    Clin Evid; 2002 Jun; (7):1369-83. PubMed ID: 12230752
    [No Abstract]   [Full Text] [Related]  

  • 26. Non-small cell lung cancer, nonsurgical, aggressive therapy. American College of Radiology. ACR Appropriateness Criteria.
    Komaki R; Sause WT; Byhardt RW; Curran WJ; Fuller D; Graham MV; Ko B; Weisenburger TH; Kaiser LR; Leibel SA; Choi NC
    Radiology; 2000 Jun; 215 Suppl():1319-30. PubMed ID: 11037549
    [No Abstract]   [Full Text] [Related]  

  • 27. [Postoperative radiotherapy after complete resection of stage II (N1) non-small-cell lung cancer: reasons for not proposing it].
    Touboul E; Deniaud-Alexandre E; Pereira R; Deluen F
    Rev Pneumol Clin; 2000 Nov; 56(5):287-92. PubMed ID: 11139758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early-stage NSCLC: the role of radiotherapy and systemic therapy.
    Bunn PA
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S31-40. PubMed ID: 19780244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heavy ion therapy for non-small cell lung cancer--new, radical radiotherapy for advanced-age patients as an alternative to surgery].
    Miyamoto T
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):209-14. PubMed ID: 12610868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Stereotactic Ablative Aadiotherapy
--A Better Choice for Operable Stage I Non-small Cell Lung Cancer?].
    Yuan D; Song Y
    Zhongguo Fei Ai Za Zhi; 2015 Jun; 18(6):325-7. PubMed ID: 26104886
    [No Abstract]   [Full Text] [Related]  

  • 31. Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer.
    Slotman BJ; Antonisse IE; Njo KH
    Radiother Oncol; 1996 Oct; 41(1):41-4. PubMed ID: 8961366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-reported short-term and long-term physical and psychologic symptoms: results of the continuous hyperfractionated accelerated [correction of acclerated] radiotherapy (CHART) randomized trial in non-small-cell lung cancer. CHART Steering Committee.
    Bailey AJ; Parmar MK; Stephens RJ
    J Clin Oncol; 1998 Sep; 16(9):3082-93. PubMed ID: 9738579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline.
    Okawara G; Ung YC; Markman BR; Mackay JA; Evans WK;
    Lung Cancer; 2004 Apr; 44(1):1-11. PubMed ID: 15013578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer].
    Kawahara M
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):335-40. PubMed ID: 7880104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of dose and fractionation in radiation therapy of curative intent for non-small cell lung cancer].
    Nieder C
    Strahlenther Onkol; 2017 Mar; 193(3):240-242. PubMed ID: 28120007
    [No Abstract]   [Full Text] [Related]  

  • 36. Radical radiotherapy and chemotherapy in localized inoperable non-small-cell lung cancer: a randomized trial.
    Gregor A; Macbeth FR; Paul J; Cram L; Hansen HH
    J Natl Cancer Inst; 1993 Jun; 85(12):997-9. PubMed ID: 7684456
    [No Abstract]   [Full Text] [Related]  

  • 37. Palliative radiotherapy regimens for non-small cell lung cancer.
    Lester JF; Macbeth FR; Toy E; Coles B
    Cochrane Database Syst Rev; 2006 Oct; (4):CD002143. PubMed ID: 17054152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Data monitoring committees and interim monitoring guidelines.
    Freidlin B; Korn EL; George SL
    Control Clin Trials; 1999 Oct; 20(5):395-407. PubMed ID: 10503800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
    Koukourakis M
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
    [No Abstract]   [Full Text] [Related]  

  • 40. [Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer or head and neck cancer].
    Plasswilm L
    Strahlenther Onkol; 2000 Dec; 176(12):583-4. PubMed ID: 11140154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.